Premier Alternatives

NeuroQore

Mountain View, CA · Founded 2012 · Privately Held (backing)

Developer of neuromodulation treatment systems designed to address depressive disorder and suicidality. NeuroQore is based in Mountain View, CA and was founded in 2012. It was valued at $10.6 million at its seed round in Sep 2025, the last priced event on record. It has raised $1.7 million across 1 recorded round; the latest was a $1.5 million seed round in Jul 2025.

PMV mark · valuation
$10.6M
Oct 2026
Priced at
its seed round
Sep 2025
Total raised
$1.7M
Last round
Seed Round
Jul 2025

NeuroQore key facts

as of Oct 2026
  • Developer of neuromodulation treatment systems designed to address depressive disorder and suicidality.
  • NeuroQore is valued at approximately $10.6M as of Oct 2026, set at its seed round, Sep 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $1.7M across 1 recorded rounds; the latest was Seed Round ($1.5M) in Jul 2025.
  • Notable investors include SOSV, IndieBio, Texas Medical Center, Federal Economic Development Agency for Southern Ontario, Ontario Brain Institute.
  • NeuroQore has filed 1 Form D with the SEC, most recently Sep 2025 ($1.5M sold to 2 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$10.6M

Valued at $10.6M at its seed round, Sep 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of NeuroQore with a free account
  • ·Watch NeuroQore: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

NeuroQore funding rounds

1 rounds
Jul 2025Seed Round$1.5MSEC filing▮
Full funding history →

NeuroQore valuation

NeuroQore was valued at $10.6 million at its seed round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has NeuroQore raised?

NeuroQore has raised $1.7 million across 1 recorded round since 2025. The largest was a $1.5 million seed round in Jul 2025.

NeuroQore has filed 1 Form D with the SEC, most recently in Sep 2025 ($1.5 million sold to 2 investors).

NeuroQore investors

5 investors are on record for NeuroQore, including SOSV, IndieBio, Texas Medical Center and Federal Economic Development Agency for Southern Ontario. The seed round in Jul 2025 drew 2 investors.

About NeuroQore

Developer of neuromodulation treatment systems designed to address depressive disorder and suicidality. The company's systems include a semiconductor switch that emits a novel magnetic pulse, enabling patients to overcome neurobehavioral conditions and have improved quality of life.

Sector
Healthcare
HQ
Mountain View, CA, United States
Founded
2012
Employees
2
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.